top of page
Publications
A viral assembly inhibitor blocks SARS-CoV-2 replication in airway epithelial cells
https://nature.com/articles/s42003-024-06130-8 The ongoing evolution of SARS-CoV-2 to evade vaccines and therapeutics underlines the need...
Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis
https://www.pnas.org/doi/10.1073/pnas.2314166121 The nonstructural protein 1 (Nsp1) of SARS-CoV-2 (Severe Acute Respiratory Syndrome...
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules
https://pubmed.ncbi.nlm.nih.gov/36558898/ Antiviral agents are needed for the treatment of SARS-CoV-2 infections and to control other...
Protocol for production and purification of SARS-CoV-2 3CLpro
https://pubmed.ncbi.nlm.nih.gov/37235475/ 3CLpro protease from SARS-CoV-2 is a primary target for COVID-19 antiviral drug development....
bottom of page